Are you Dr. Savaraj?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 46 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1201 Nw 16th St
Miami, FL 33125Phone+1 305-575-3143Fax+1 305-575-7047
Summary
- Dr. Niramol Savaraj, MD is an oncologist in Miami, Florida. She is currently licensed to practice medicine in Texas and District of Columbia. She is affiliated with Miami Veterans Affairs Healthcare System.
Education & Training
- Medical College of GeorgiaFellowship, Hematology and Medical Oncology, 1978 - 1978
- University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 1976 - 1978
- Quinnipiac University Frank H. Netter MD School of Medicine/St Vincent's Medical CenterResidency, Internal Medicine, 1973 - 1976
- Mahidol University Faculty of MedicineClass of 1972
Certifications & Licensure
- TX State Medical License 1979 - 2025
- DC State Medical License 1975 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Trial of pasireotideLAR and Topotecan in Relapsed or Refractory Small Cell Lung Cancer Start of enrollment: 2011 Jul 01
Publications & Presentations
PubMed
- A platform of ADAPTive scaffolds: development of CDR-H3 β-hairpin mimics into covalent inhibitors of the PD1/PDL1 immune checkpoint.Sarah H Naylon, Alexis D Richaud, Guangkuan Zhao, Linda Bui, Craig P Dufresne
RSC Chemical Biology. 2024-11-04 - 8 citationsDual inhibition of IDO1/TDO2 enhances anti-tumor immunity in platinum-resistant non-small cell lung cancer.Chunjing Wu, Sydney A Spector, George Theodoropoulos, Dan J M Nguyen, Emily Y Kim
Cancer & Metabolism. 2023-05-24 - 4 citationsExploiting the Innate Plasticity of the Programmed Cell Death-1 (PD1) Receptor to Design Pembrolizumab H3 Loop Mimics.Alexis D Richaud, Mehdi Zaghouani, Guangkuan Zhao, Medhi Wangpaichitr, Niramol Savaraj
Chembiochem. 2022-11-04